array:34 [ "id" => array:1 [ 0 => array:1 [ "value" => "2436" ] ] "isin" => array:1 [ 0 => array:1 [ "value" => "DE000LS9CJM7" ] ] "wkn" => array:1 [ 0 => array:1 [ "value" => "LS9CJM" ] ] "name" => array:1 [ 0 => array:1 [ "value" => "KA76227F" ] ] "short_description" => array:1 [ 0 => array:1 [ "value" => "Healthcare Demography" ] ] "long_description" => array:1 [ 0 => array:1 [ "value" => """ Das Wikifolio Healthcare Demographie soll überwiegend in Aktien investieren, die meiner Meinung nach vom demographischen Wandel und grundlegenden Trends im Bereich Medizintechnik oder Pharma profitieren werden. \r\n \r\n Es sollen Aktien gewählt werden, die sich auf grundlegenden Vergleichsdaten vom Wettbewerb durch klare Fokussierung unterscheiden.\r\n \r\n Der überwiegende Teil der Aktien soll langfristig bis mittelfristig gehalten werden. \r\n \r\n Die Aktien sollen überwiegend aus dem europäischen oder nordamerikanischen Raum stammen. Je nach Marktsituation kann auch in ausgewählte ETF investiert werden.\r\n """ ] ] "status" => array:1 [ 0 => array:1 [ "value" => "Investable" ] ] "trader_name" => array:1 [ 0 => array:1 [ "value" => "ArBriest" ] ] "symbol" => array:1 [ 0 => array:1 [ "value" => "WFKA76227F" ] ] "creation_date" => array:1 [ 0 => array:1 [ "value" => "1358365007" ] ] "issuing_date" => array:1 [ 0 => array:1 [ "value" => "1406251831" ] ] "daily_free_relative" => array:1 [ 0 => array:1 [ "value" => "0.95" ] ] "performance_free_relative" => array:1 [ 0 => array:1 [ "value" => "5" ] ] "cash" => array:1 [ 0 => array:1 [ "value" => "569.554" ] ] "url" => array:1 [ 0 => array:1 [ "value" => "https://www.wikifolio.com/de/ch/w/wfka76227f" ] ] "href" => array:1 [ 0 => array:1 [ "value" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9cjm7" ] ] "wikifolio_tags" => array:1 [ 0 => array:1 [ "value" => "a:8:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:11:"fundamental";s:16:"ShortDescription";s:20:"Fundamentale Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:3;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:4;a:3:{s:4:"Name";s:10:"schwer-usa";s:16:"ShortDescription";s:15:"Schwerpunkt USA";s:8:"TagGroup";s:35:"ExtendedSearchInvestmentRegionGroup";}i:5;a:3:{s:4:"Name";s:8:"langf-st";s:16:"ShortDescription";s:23:"Mittel- bis langfristig";s:8:"TagGroup";s:36:"ExtendedSearchInvestmentHorizonGroup";}i:6;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:7;a:3:{s:4:"Name";s:10:"regelm-akt";s:16:"ShortDescription";s:24:"Regelmäßige Aktivität";s:8:"TagGroup";s:18:"Qualitätsmerkmale";}}" ] ] "rankings" => array:1 [ 0 => array:1 [ "value" => "a:9:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:455796.091443;s:5:"Index";i:211;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:649.097667122023;s:5:"Index";i:197;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:4.055010856;s:5:"Index";i:5145;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:-2.414135017;s:5:"Index";i:51006;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:332.096771588716;s:5:"Index";i:1814;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:4.209016196;s:5:"Index";i:23937;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:-6.821887807;s:5:"Index";i:54883;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-47.1072507607;s:5:"Index";i:77074;}i:8;a:4:{s:4:"Name";s:11:"sharperatio";s:16:"ShortDescription";s:23:"Sharpe Ratio (365 Tage)";s:5:"Value";d:-0.070973064846;s:5:"Index";i:30906;}}" ] ] "wikifolio_items" => array:1 [ 0 => array:1 [ "value" => "a:24:{i:0;a:8:{s:4:"ISIN";s:12:"US70975L1070";s:3:"WKN";s:6:"A14Y65";s:16:"ShortDescription";s:13:"PENUMBRA INC.";s:13:"AbsoluteValue";d:274;s:13:"RelativeValue";d:0.48107790857526317;s:12:"AbsoluteGain";d:69.5;s:12:"RelativeGain";d:0.33985330073349634;s:8:"Quantity";d:1;}i:1;a:8:{s:4:"ISIN";s:12:"US80810D1037";s:3:"WKN";s:6:"A2PY7M";s:16:"ShortDescription";s:23:"SCHRODINGER INC.DL -,01";s:13:"AbsoluteValue";d:38.43;s:13:"RelativeValue";d:0.06747381031586629;s:12:"AbsoluteGain";d:-105.75;s:12:"RelativeGain";d:-0.733458177278402;s:8:"Quantity";d:3;}i:2;a:8:{s:4:"ISIN";s:12:"US89377M1099";s:3:"WKN";s:6:"A2PH5P";s:16:"ShortDescription";s:17:"TRANSMEDICS GROUP";s:13:"AbsoluteValue";d:1031.36;s:13:"RelativeValue";d:1.8108193860882607;s:12:"AbsoluteGain";d:-601.04;s:12:"RelativeGain";d:-0.3681940700808625;s:8:"Quantity";d:16;}i:3;a:8:{s:4:"ISIN";s:12:"US92686J1060";s:3:"WKN";s:6:"A12GD6";s:16:"ShortDescription";s:25:"VIKING THERAPEUT.DL -,005";s:13:"AbsoluteValue";d:3429;s:13:"RelativeValue";d:6.020496892352472;s:12:"AbsoluteGain";d:-2920.995447154425;s:12:"RelativeGain";d:-0.45999961282860263;s:8:"Quantity";d:135;}i:4;a:8:{s:4:"ISIN";s:12:"US2788651006";s:3:"WKN";s:6:"854545";s:16:"ShortDescription";s:10:"ECOLAB INC";s:13:"AbsoluteValue";d:706.5;s:13:"RelativeValue";d:1.2404435854322022;s:12:"AbsoluteGain";d:-5.7;s:12:"RelativeGain";d:-0.008003369839932602;s:8:"Quantity";d:3;}i:5;a:8:{s:4:"ISIN";s:12:"US45784P1012";s:3:"WKN";s:6:"A0MQX8";s:16:"ShortDescription";s:25:"INSULET CORP. DL -,001";s:13:"AbsoluteValue";d:1906.5;s:13:"RelativeValue";d:3.3473541339370043;s:12:"AbsoluteGain";d:-567;s:12:"RelativeGain";d:-0.22922983626440266;s:8:"Quantity";d:15;}i:6;a:8:{s:4:"ISIN";s:12:"US4500561067";s:3:"WKN";s:6:"A2ATTS";s:16:"ShortDescription";s:25:"IRHYTHM TECHN.INC.DL-,001";s:13:"AbsoluteValue";d:93.5;s:13:"RelativeValue";d:0.16416344690433252;s:12:"AbsoluteGain";d:-41.5;s:12:"RelativeGain";d:-0.3074074074074074;s:8:"Quantity";d:1;}i:7;a:8:{s:4:"ISIN";s:12:"US3773221029";s:3:"WKN";s:6:"A14VCK";s:16:"ShortDescription";s:25:"GLAUKOS CORP. DL-,001";s:13:"AbsoluteValue";d:1962;s:13:"RelativeValue";d:3.4447987468053514;s:12:"AbsoluteGain";d:55.999999999998;s:12:"RelativeGain";d:0.02938090241343019;s:8:"Quantity";d:18;}i:8;a:8:{s:4:"ISIN";s:12:"US4330001060";s:3:"WKN";s:6:"A2QMYY";s:16:"ShortDescription";s:25:"HIMS+HERS HERS A DL-,0001";s:13:"AbsoluteValue";d:2022;s:13:"RelativeValue";d:3.5501442742305915;s:12:"AbsoluteGain";d:315.75;s:12:"RelativeGain";d:0.18505494505494505;s:8:"Quantity";d:75;}i:9;a:8:{s:4:"ISIN";s:12:"US64125C1099";s:3:"WKN";s:6:"900964";s:16:"ShortDescription";s:27:"NEUROCRINE BIOSCIENCES INC.";s:13:"AbsoluteValue";d:134.6;s:13:"RelativeValue";d:0.23632513319062198;s:12:"AbsoluteGain";d:3.3;s:12:"RelativeGain";d:0.02513328255902513;s:8:"Quantity";d:1;}i:10;a:8:{s:4:"ISIN";s:12:"US5255582018";s:3:"WKN";s:6:"A0LB2B";s:16:"ShortDescription";s:25:"LEMAITRE VASCULAR DL -,01";s:13:"AbsoluteValue";d:320;s:13:"RelativeValue";d:0.5618428129346139;s:12:"AbsoluteGain";d:93.473684210528;s:12:"RelativeGain";d:0.41263940520447145;s:8:"Quantity";d:4;}i:11;a:8:{s:4:"ISIN";s:12:"US5324571083";s:3:"WKN";s:6:"858560";s:16:"ShortDescription";s:9:"ELI LILLY";s:13:"AbsoluteValue";d:41439.1;s:13:"RelativeValue";d:72.75706409212113;s:12:"AbsoluteGain";d:14119.097777777773;s:12:"RelativeGain";d:0.5168044154217978;s:8:"Quantity";d:43;}i:12;a:8:{s:4:"ISIN";s:12:"US5588681057";s:3:"WKN";s:6:"A2APCZ";s:16:"ShortDescription";s:25:"MADRIGAL PHARMAC. DL-,01";s:13:"AbsoluteValue";d:4316;s:13:"RelativeValue";d:7.577854939455605;s:12:"AbsoluteGain";d:1446;s:12:"RelativeGain";d:0.5038327526132405;s:8:"Quantity";d:10;}i:13;a:8:{s:4:"ISIN";s:12:"US46120E6023";s:3:"WKN";s:6:"888024";s:16:"ShortDescription";s:25:"INTUITIVE SURGIC. DL-,001";s:13:"AbsoluteValue";d:3562;s:13:"RelativeValue";d:6.254012811478421;s:12:"AbsoluteGain";d:-318;s:12:"RelativeGain";d:-0.08195876288659794;s:8:"Quantity";d:10;}i:14;a:8:{s:4:"ISIN";s:12:"CH1499059983";s:3:"WKN";s:6:"A424UK";s:16:"ShortDescription";s:25:"ROCHE HOLDING PS SF -,001";s:13:"AbsoluteValue";d:349.5;s:13:"RelativeValue";d:0.6136376972520237;s:12:"AbsoluteGain";d:51.6;s:12:"RelativeGain";d:0.1732124874118832;s:8:"Quantity";d:1;}i:15;a:8:{s:4:"ISIN";s:12:"GB0009895292";s:3:"WKN";s:6:"886455";s:16:"ShortDescription";s:11:"ASTRAZENECA";s:13:"AbsoluteValue";d:765.5;s:13:"RelativeValue";d:1.3440333540670217;s:12:"AbsoluteGain";d:48;s:12:"RelativeGain";d:0.06689895470383275;s:8:"Quantity";d:5;}i:16;a:8:{s:4:"ISIN";s:12:"DK0060257814";s:3:"WKN";s:6:"A0YJW7";s:16:"ShortDescription";s:18:"ZEALAND PHARMA A-S";s:13:"AbsoluteValue";d:1505.6;s:13:"RelativeValue";d:2.6434704348573583;s:12:"AbsoluteGain";d:-3443.4;s:12:"RelativeGain";d:-0.6957769246312386;s:8:"Quantity";d:40;}i:17;a:8:{s:4:"ISIN";s:12:"DK0062266474";s:3:"WKN";s:6:"A3D9NV";s:16:"ShortDescription";s:25:"GUBRA APS DK 1";s:13:"AbsoluteValue";d:1389;s:13:"RelativeValue";d:2.4387489598943084;s:12:"AbsoluteGain";d:-1378.8;s:12:"RelativeGain";d:-0.49815738131367876;s:8:"Quantity";d:30;}i:18;a:8:{s:4:"ISIN";s:12:"DK0062498333";s:3:"WKN";s:6:"A3EU6F";s:16:"ShortDescription";s:25:"NOVO-NORDISK AS B DK 0,1";s:13:"AbsoluteValue";d:11062.5;s:13:"RelativeValue";d:19.423081619028647;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:295;}i:19;a:8:{s:4:"ISIN";s:12:"IL0011595993";s:3:"WKN";s:6:"A2PP3A";s:16:"ShortDescription";s:23:"INMODE LTD IS -,01";s:13:"AbsoluteValue";d:1150.895;s:13:"RelativeValue";d:2.0206940131011955;s:12:"AbsoluteGain";d:-2511.705000000034;s:12:"RelativeGain";d:-0.6857710369682768;s:8:"Quantity";d:101;}i:20;a:8:{s:4:"ISIN";s:12:"US0311621009";s:3:"WKN";s:6:"867900";s:16:"ShortDescription";s:25:"AMGEN INC. DL-,0001";s:13:"AbsoluteValue";d:892.35;s:13:"RelativeValue";d:1.5667513566318836;s:12:"AbsoluteGain";d:52.35;s:12:"RelativeGain";d:0.06232142857142857;s:8:"Quantity";d:3;}i:21;a:8:{s:4:"ISIN";s:12:"US0378331005";s:3:"WKN";s:6:"865985";s:16:"ShortDescription";s:10:"APPLE INC.";s:13:"AbsoluteValue";d:5146;s:13:"RelativeValue";d:9.03513473550476;s:12:"AbsoluteGain";d:1500.96;s:12:"RelativeGain";d:0.4117814893663718;s:8:"Quantity";d:20;}i:22;a:8:{s:4:"ISIN";s:12:"US2289031005";s:3:"WKN";s:6:"900006";s:16:"ShortDescription";s:25:"ARTIVION INC. DL-,01";s:13:"AbsoluteValue";d:1288;s:13:"RelativeValue";d:2.261417322061821;s:12:"AbsoluteGain";d:-134.50000000003;s:12:"RelativeGain";d:-0.0945518453427256;s:8:"Quantity";d:70;}i:23;a:8:{s:4:"ISIN";s:12:"US1011371077";s:3:"WKN";s:6:"884113";s:16:"ShortDescription";s:15:"BOSTON SCIEN CP";s:13:"AbsoluteValue";d:806.3;s:13:"RelativeValue";d:1.415668312716185;s:12:"AbsoluteGain";d:-613.7;s:12:"RelativeGain";d:-0.4321830985915493;s:8:"Quantity";d:20;}}" ] ] "licence_switzerland" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf1m" => array:1 [ 0 => array:1 [ "value" => "4.05501" ] ] "perf12m" => array:1 [ 0 => array:1 [ "value" => "-2.41413" ] ] "perfever" => array:1 [ 0 => array:1 [ "value" => "332.097" ] ] "aum" => array:1 [ 0 => array:1 [ "value" => "455796" ] ] "topwikis" => array:1 [ 0 => array:1 [ "value" => "197" ] ] "created" => array:1 [ 0 => array:1 [ "value" => "1649766873" ] ] "changed" => array:1 [ 0 => array:1 [ "value" => "1781644815" ] ] "solid_valor" => array:1 [ 0 => array:1 [ "value" => "25025647" ] ] "solid_bc" => array:1 [ 0 => array:1 [ "value" => "LSD" ] ] "solid_bc_id" => array:1 [ 0 => array:1 [ "value" => "2913" ] ] "solid_cc" => array:1 [ 0 => array:1 [ "value" => "EUR" ] ] "solid_cc_id" => array:1 [ 0 => array:1 [ "value" => "814" ] ] "fullquote_link" => array:1 [ 0 => array:1 [ "value" => "wikifolio/wfka76227f-lgsz-zt-25025647/lsd/eur" ] ] "solid_changed" => array:1 [ 0 => array:1 [ "value" => "1661275828" ] ] ]